556 related articles for article (PubMed ID: 27998232)
1. Medicare D Subsidies and Racial Disparities in Persistence and Adherence With Hormonal Therapy.
Biggers A; Shi Y; Charlson J; Smith EC; Smallwood AJ; Nattinger AB; Laud PW; Neuner JM
J Clin Oncol; 2016 Dec; 34(36):4398-4404. PubMed ID: 27998232
[TBL] [Abstract][Full Text] [Related]
2. Association Between Out-Of-Pocket Costs, Race/Ethnicity, and Adjuvant Endocrine Therapy Adherence Among Medicare Patients With Breast Cancer.
Farias AJ; Du XL
J Clin Oncol; 2017 Jan; 35(1):86-95. PubMed ID: 28034069
[TBL] [Abstract][Full Text] [Related]
3. Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data.
Farias AJ; Wu WH; Du XL
BMC Cancer; 2018 Dec; 18(1):1214. PubMed ID: 30514270
[TBL] [Abstract][Full Text] [Related]
4. Racial and ethnic disparities in use of 17-alpha hydroxyprogesterone caproate for prevention of preterm birth.
Yee LM; Liu LY; Sakowicz A; Bolden JR; Miller ES
Am J Obstet Gynecol; 2016 Mar; 214(3):374.e1-6. PubMed ID: 26829989
[TBL] [Abstract][Full Text] [Related]
5. Racial/Ethnic Differences in Cost-Related Nonadherence and Medicare Part D: A Longitudinal Comparison.
Bakk L
J Health Care Poor Underserved; 2015 Nov; 26(4):1132-48. PubMed ID: 26548668
[TBL] [Abstract][Full Text] [Related]
6. Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative.
Livaudais JC; Lacroix A; Chlebowski RT; Li CI; Habel LA; Simon MS; Thompson B; Erwin DO; Hubbell FA; Coronado GD
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):365-73. PubMed ID: 23275187
[TBL] [Abstract][Full Text] [Related]
7. Assessing the difference in racial and ethnic disparities in access to and use of care between Traditional Medicare and Medicare Advantage.
Gangopadhyaya A; Zuckerman S; Rao N
Health Serv Res; 2023 Aug; 58(4):914-923. PubMed ID: 36894493
[TBL] [Abstract][Full Text] [Related]
8. Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer.
Ma TM; Agarwal N; Mahal B; Barragan-Carrillo R; Spratt D; Rettig MB; Valle LF; Steinberg ML; Garraway I; Vapiwala N; Xiang M; Kishan AU
JAMA Netw Open; 2023 Dec; 6(12):e2345906. PubMed ID: 38039002
[TBL] [Abstract][Full Text] [Related]
9. Racial and Ethnic Disparities in Meeting MTM Eligibility Criteria Based on Star Ratings Compared with the Medicare Modernization Act.
Spivey CA; Wang J; Qiao Y; Shih YT; Wan JY; Kuhle J; Dagogo-Jack S; Cushman WC; Chisholm-Burns M
J Manag Care Spec Pharm; 2018 Feb; 24(2):97-107. PubMed ID: 29384031
[TBL] [Abstract][Full Text] [Related]
10. Racial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction.
Lauffenburger JC; Robinson JG; Oramasionwu C; Fang G
Circulation; 2014 Feb; 129(7):754-63. PubMed ID: 24326988
[TBL] [Abstract][Full Text] [Related]
11. Did Medicare Part D reduce disparities?
Zissimopoulos J; Joyce GF; Scarpati LM; Goldman DP
Am J Manag Care; 2015 Feb; 21(2):119-28. PubMed ID: 25880361
[TBL] [Abstract][Full Text] [Related]
12. Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer.
Hershman DL; Tsui J; Wright JD; Coromilas EJ; Tsai WY; Neugut AI
J Clin Oncol; 2015 Mar; 33(9):1053-9. PubMed ID: 25691670
[TBL] [Abstract][Full Text] [Related]
13. Racial/Ethnic and Socioeconomic Disparities in Use of Direct-Acting Antivirals Among Medicare Beneficiaries with Chronic Hepatitis C, 2014-2016.
Jung J; Du P; Feldman R; Kong L; Riley T
J Manag Care Spec Pharm; 2019 Nov; 25(11):1236-1242. PubMed ID: 31663464
[TBL] [Abstract][Full Text] [Related]
14. Has Medicare Part D reduced racial/ethnic disparities in prescription drug use and spending?
Mahmoudi E; Jensen GA
Health Serv Res; 2014 Apr; 49(2):502-25. PubMed ID: 24102408
[TBL] [Abstract][Full Text] [Related]
15. Impact of Medicare Part D on Racial Disparities in Adherence to Cardiovascular Medications Among the Elderly.
Hussein M; Waters TM; Chang CF; Bailey JE; Brown LM; Solomon DK
Med Care Res Rev; 2016 Aug; 73(4):410-36. PubMed ID: 26577228
[TBL] [Abstract][Full Text] [Related]
16. Racial and geographic disparities in adherence and discontinuation to adjuvant endocrine therapy in Texas Medicaid-insured patients with breast cancer.
Farias AJ; Wu WH; Du XL
Med Oncol; 2018 Jun; 35(7):113. PubMed ID: 29926275
[TBL] [Abstract][Full Text] [Related]
17. Understanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression Among HIV Patients in the United States.
Beer L; Mattson CL; Bradley H; Skarbinski J;
Medicine (Baltimore); 2016 Mar; 95(13):e3171. PubMed ID: 27043679
[TBL] [Abstract][Full Text] [Related]
18. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
[TBL] [Abstract][Full Text] [Related]
19. Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors.
Camacho FT; Tan X; Alcalá HE; Shah S; Anderson RT; Balkrishnan R
Medicine (Baltimore); 2017 Jun; 96(24):e7147. PubMed ID: 28614244
[TBL] [Abstract][Full Text] [Related]
20. Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014.
Purnell TS; Luo X; Cooper LA; Massie AB; Kucirka LM; Henderson ML; Gordon EJ; Crews DC; Boulware LE; Segev DL
JAMA; 2018 Jan; 319(1):49-61. PubMed ID: 29297077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
